Cyanidin-3-O-glucoside 通过上调 miR-214-5p 抑制 β-catenin/MGMT 通路逆转胶质瘤细胞的化疗耐药性
–Earnings in-line; Mgmt. changes imply a new round of expansion
1H23 core profit +10% YoY; positive on the structural growth and mgmt. execution